Karen Smith

2017

In 2017, Karen Smith earned a total compensation of $2.9M as Former Executive Vice President, Research and Development, CMO at Jazz Pharmaceuticals, a 39% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$287,700
Option Awards$915,873
Salary$516,923
Stock Awards$1,176,530
Other$10,722
Total$2,907,748

Smith received $1.2M in stock awards, accounting for 40% of the total pay in 2017.

Smith also received $287.7K in non-equity incentive plan, $915.9K in option awards, $516.9K in salary and $10.7K in other compensation.

Rankings

In 2017, Karen Smith's compensation ranked 3,756th out of 14,666 executives tracked by ExecPay. In other words, Smith earned more than 74.4% of executives.

ClassificationRankingPercentile
All
3,756
out of 14,666
74th
Division
Manufacturing
1,307
out of 5,772
77th
Major group
Chemicals And Allied Products
366
out of 2,075
82nd
Industry group
Drugs
282
out of 1,731
84th
Industry
Pharmaceutical Preparations
223
out of 1,333
83rd
Source: SEC filing on June 15, 2018.

Smith's colleagues

We found five more compensation records of executives who worked with Karen Smith at Jazz Pharmaceuticals in 2017.

2017

Bruce Cozadd

Jazz Pharmaceuticals

Chief Executive Officer

2017

Suzanne Hooper

Jazz Pharmaceuticals

Executive Vice President and GC

2017

Matthew Young

Jazz Pharmaceuticals

Chief Financial Officer

2017

Russell Cox

Jazz Pharmaceuticals

Chief Operating Officer

2017

Michael Miller

Jazz Pharmaceuticals

Executive Vice President U.S Commercial

You may also like